Inducers of heme oxygenase-1

被引:162
作者
Ferrandiz, M. L. [1 ]
Devesa, I. [1 ]
机构
[1] Univ Valencia, Dept Pharmacol, Fac Pharm, E-46100 Valencia, Spain
关键词
heme oxygenase-1; chemical inducers; pharmacological modulation;
D O I
10.2174/138161208783597399
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Heme oxygenase-1 (HO-1) is an inducible rate-limiting enzyme which catalyzes group heme into carbon monoxide, iron and bilirubin. In the recent years, HO-1 expression has been reported as an important protective endogenous mechanism against physical, chemical and biological stress. In this regard, induction of this enzyme has shown beneficial effects in several pathologic conditions, such as inflammatory processes, atherosclerosis, carcinogenesis, ischemia-reperfusion systems or degenerative diseases. Complex intracellular signalling cascades mediate the expression of HO-1 in response to external stimuli, Transcription factors, as nuclear factor E2-related factor-2, activator protein-1, and nuclear factor-kappa B, and some of their upstream kinases, mitogen-activated protein kinases, phosphatidylinositol 3-kinase, or protein kinases A, C are responsible of the HO-1 gene expression. The purpose of this article is to review the increasing number of natural and synthetic molecules reported to induce HO-1 as additive mechanism responsible for their therapeutic effects; experimental and pathological conditions as well as possible signalling mechanism involved in HO-1 expression by this compounds are described. Controlled upregulation of this enzyme, or its catalytic activity, has shown antioxidant, anti-proliferative, anti-apoptotic and anti-inflammatory properties. For this reason, pharmacologic modulation of HO-1 system may represent an effective and cooperative strategy to intervene in several pathologic conditions.
引用
收藏
页码:473 / 486
页数:14
相关论文
共 223 条
[11]   Ginseng pharmacology - Multiple constituents and multiple actions [J].
Attele, AS ;
Wu, JA ;
Yuan, CS .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) :1685-1693
[12]   Heme oxygenase vs. nitric oxide synthase in signaling mediating sildenafil citrate action [J].
Aziz, M. Talaat Abdel ;
El-Asmer, Mohamed Farid ;
Mostafa, Taymour ;
Mostafa, Samia ;
Atta, Hazem ;
Wassef, M. Abdel Aziz ;
Fouad, Hanan ;
Rashed, Laila ;
Sabry, Dina ;
Mahfouz, Soheir .
JOURNAL OF SEXUAL MEDICINE, 2007, 4 (04) :1098-1107
[13]   Heme oxygenase-1: a therapeutic amplification funnel [J].
Bach, FH .
FASEB JOURNAL, 2005, 19 (10) :1216-1219
[14]  
BAI A, 2007, DIG DIS SCI 0612
[15]   Curcurnin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element [J].
Balogun, E ;
Hoque, M ;
Gong, PF ;
Killeen, E ;
Green, CJ ;
Foresti, R ;
Alam, J ;
Motterlini, R .
BIOCHEMICAL JOURNAL, 2003, 371 :887-895
[16]   Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression [J].
Basseres, D. S. ;
Baldwin, A. S. .
ONCOGENE, 2006, 25 (51) :6817-6830
[17]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[18]   Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing [J].
Biteman, Benjamin ;
Hassan, Iram R. ;
Walker, Everald ;
Leedom, Alexander J. ;
Dunn, Michael ;
Seta, Francesca ;
Laniado-Schwartzman, Michal ;
Gronert, Karsten .
FASEB JOURNAL, 2007, 21 (09) :2257-2266
[19]   Understanding eNOS for pharmacological modulation of endothelial function: A translational view [J].
Braam, Branko ;
Verhaar, Marianne C. .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (17) :1727-1740
[20]  
BRUNE B, 1987, MOL PHARMACOL, V32, P497